<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0006847.ref032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hunsperger</surname>
   <given-names>EA</given-names>
  </name>, 
  <name>
   <surname>Yoksan</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Buchy</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Nguyen</surname>
   <given-names>VC</given-names>
  </name>, 
  <name>
   <surname>Sekaran</surname>
   <given-names>SD</given-names>
  </name>, 
  <name>
   <surname>Enria</surname>
   <given-names>DA</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests</article-title>. 
  <source>Emerging Infectious Diseases</source>. 
  <year>2009</year>;
  <volume>15</volume>(
  <issue>3</issue>):
  <fpage>436</fpage>–
  <lpage>439</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1503.080923" xmlns:xlink="http://www.w3.org/1999/xlink">10.3201/eid1503.080923</ext-link>
  <?supplied-pmid 19239758?>
  <pub-id pub-id-type="pmid">19239758</pub-id>
 </mixed-citation>
</ref>
